Hoth Therapeutics HOTH

$ 0.84 2.0%

Quarterly report 2024-Q3
added 11-12-2024

Hoth Therapeutics Balance Sheet 2011-2024 | HOTH

Annual Balance Sheet Hoth Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-9.24 M	-	-	-2.63 M	-1.69 M	-283 K	-1.23 M	-	-	-	-	-	-
Long Term Debt	26.3 K	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	28.8 K	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	285 K	-	-	-	-	-	-	-	-	-
Total Current Liabilities	679 K	1.39 M	868 K	312 K	440 K	349 K	-	-	-	-	-	-	-
Total Liabilities	705 K	1.64 M	1.1 M	597 K	440 K	349 K	49.5 K	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-52.9 M	-45.1 M	-33.7 M	-19.4 M	-12.2 M	-4.51 M	-2.02 M	-	-	-	-	-	-
Total Assets	9.52 M	6.76 M	11 M	5.24 M	2.84 M	504 K	1.23 M	-	-	-	-	-	-
Cash and Cash Equivalents	9.29 M	6.43 M	8.54 M	2.63 M	1.69 M	283 K	-	-	-	-	-	-	-
Book Value	8.82 M	5.12 M	9.88 M	4.65 M	2.4 M	155 K	1.18 M	-	-	-	-	-	-
Total Shareholders Equity	8.82 M	5.12 M	9.88 M	4.65 M	2.4 M	155 K	1.18 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Hoth Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	2.71 K	11 K	18.9 K	26.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	2.71 K	11 K	18.9 K	26.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	813 K	692 K	659 K	705 K	1.58 M	1.97 M	1.6 M	1.64 M	1.28 M	1.03 M	1.06 M	1.1 M	1.84 M	1.45 M	1.04 M	597 K	597 K	597 K	597 K	440 K	440 K	440 K	440 K	349 K	349 K	349 K	349 K	49.5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-58.7 M	-56.6 M	-55 M	-52.9 M	-51.2 M	-49.2 M	-47.3 M	-45.1 M	-41.6 M	-39 M	-36.3 M	-33.7 M	-30.2 M	-27 M	-23.7 M	-19.4 M	-19.4 M	-19.4 M	-19.4 M	-12.2 M	-12.2 M	-12.2 M	-12.2 M	-4.51 M	-4.51 M	-4.51 M	-4.51 M	-2.02 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	8.31 M	10 M	8.49 M	9.52 M	12.1 M	11.9 M	13.5 M	6.76 M	9.89 M	12.3 M	8.95 M	11 M	15.2 M	18 M	21 M	5.24 M	5.24 M	5.24 M	5.24 M	2.84 M	2.84 M	2.84 M	2.84 M	504 K	504 K	504 K	504 K	1.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	8 M	9.65 M	7.56 M	9.29 M	11.8 M	11.5 M	13 M	6.43 M	8.94 M	11.3 M	6.38 M	8.54 M	12.4 M	15.9 M	19.3 M	2.63 M	2.63 M	2.63 M	2.63 M	1.69 M	1.69 M	1.69 M	1.69 M	283 K	283 K	283 K	283 K	1.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	7.49 M	9.34 M	7.83 M	8.82 M	10.5 M	9.95 M	11.9 M	5.12 M	8.61 M	11.2 M	7.88 M	9.88 M	13.3 M	16.6 M	19.9 M	4.65 M	4.65 M	4.65 M	4.65 M	2.4 M	2.4 M	2.4 M	2.4 M	155 K	155 K	155 K	155 K	1.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	7.49 M	9.34 M	7.83 M	8.82 M	10.5 M	9.95 M	11.9 M	5.12 M	8.61 M	11.2 M	7.88 M	9.88 M	13.3 M	16.6 M	19.9 M	4.65 M	4.65 M	4.65 M	4.65 M	2.4 M	2.4 M	2.4 M	2.4 M	155 K	155 K	155 K	155 K	1.18 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency